{2-[2-(4-{[5-(dimethylcarbamoyl)pyridin-2-yl]oxy}piperidin-1-yl)-2-oxoethyl]phenyl}boronic acid

ID: ALA4093246

PubChem CID: 137654706

Max Phase: Preclinical

Molecular Formula: C21H26BN3O5

Molecular Weight: 411.27

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)C(=O)c1ccc(OC2CCN(C(=O)Cc3ccccc3B(O)O)CC2)nc1

Standard InChI:  InChI=1S/C21H26BN3O5/c1-24(2)21(27)16-7-8-19(23-14-16)30-17-9-11-25(12-10-17)20(26)13-15-5-3-4-6-18(15)22(28)29/h3-8,14,17,28-29H,9-13H2,1-2H3

Standard InChI Key:  SFPKXCDZSAEQNQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
   21.9513  -20.6361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9502  -21.4556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6582  -21.8646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3679  -21.4552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3650  -20.6325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6564  -20.2272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6580  -22.6818    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
   21.9502  -23.0902    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.3656  -23.0906    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.2421  -21.8637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5347  -21.4545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8267  -21.8626    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.5354  -20.6373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.1221  -21.4481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4162  -21.8527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4113  -22.6702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1185  -23.0815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8306  -22.6753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7017  -23.0756    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.9959  -22.6637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0024  -21.8466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2974  -21.4349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5868  -21.8403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5857  -22.6617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2913  -23.0698    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8805  -21.4294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8831  -20.6122    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1714  -21.8357    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4650  -21.4248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1688  -22.6529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  7  8  1  0
  7  9  1  0
  2 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 12 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 28 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4093246

    ---

Associated Targets(Human)

LIPE Tchem Hormone sensitive lipase (506 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Butyrylcholinesterase (7174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Lipe Hormone-sensitive lipase (209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 411.27Molecular Weight (Monoisotopic): 411.1966AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Ogiyama T, Yamaguchi M, Kurikawa N, Honzumi S, Terayama K, Nagaoka N, Yamamoto Y, Kimura T, Sugiyama D, Inoue SI..  (2017)  Design, synthesis, and pharmacological evaluation of a novel series of hormone sensitive lipase inhibitor.,  25  (17): [PMID:28756012] [10.1016/j.bmc.2017.07.028]

Source